Latest Asx Market News

Page 6 of 14
ReNerve has moved its NervAlign Nerve Guide Matrix into stage 3 of commercial development, a key step toward FDA submission and eventual market entry. This progress supports the company’s ambition to provide surgeons with an alternative to donor nerves for repairing severe peripheral nerve injuries.
Ada Torres
Ada Torres
15 Apr 2026
Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.
Ada Torres
Ada Torres
14 Apr 2026
SQX Resources continues to impress with thick, high-grade gold intercepts near surface at its Red Bird project in Arizona, reinforcing open-pit potential ahead of further assays and geophysical work.
Maxwell Dee
Maxwell Dee
13 Apr 2026
Citigroup Global Markets Australia has announced a fully franked dividend for RIO CitiFirst Self-Funding Instalments, with dividend proceeds directed to reduce outstanding loan amounts. The record and ex-dividend dates align with those of RIO ordinary shares.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Cauldron Energy Limited has clarified that its recent share price jump is driven by easing geopolitical tensions and a buoyant uranium market, with no undisclosed material information influencing trading.
Maxwell Dee
Maxwell Dee
1 Apr 2026
ARN Media is confronting a substantial legal claim from former contractor Jacqueline Henderson, who alleges adverse action and bullying following her contract termination. The case also challenges previous ASX disclosures, with compensation sought exceeding $82 million.
Elise Vega
Elise Vega
31 Mar 2026
The Takeovers Panel has declared unacceptable circumstances in Humm Group's handling of Credit Corp's takeover proposal, citing misleading disclosures and insider share acquisitions that cloud market fairness.
Claire Turing
Claire Turing
18 Mar 2026
iCandy Interactive is exploring a US listing for its subsidiary Lemon Sky Studios to unlock shareholder value, while facing a likely ASX delisting due to audit delays. The company also plans a capital raise to support these initiatives.
Sophie Babbage
Sophie Babbage
13 Mar 2026
Kjerulf David Hastings Ainsworth has initiated a second proportional takeover bid for 5.5% of Ainsworth Game Technology shares at $1.30 each, offering shareholders a significant premium and cash certainty. The move underscores Ainsworth’s belief that AGI remains undervalued amid a low likelihood of competing bids.
Victor Sage
Victor Sage
12 Mar 2026
Sports Entertainment Group Limited has announced a significant on-market share buy-back program, aiming to repurchase up to 10% of its shares over the next year starting March 2026. The move reflects the board's confidence in the company's underlying value amid current market pricing.
Victor Sage
Victor Sage
10 Mar 2026
Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.
Ada Torres
Ada Torres
23 Feb 2026
Global X Management (AUS) Limited has announced estimated distributions for three ETFs listed on the ASX AQUA Market for the period ending 28 February 2026, providing key dates and dividend reinvestment plan eligibility.
Claire Turing
Claire Turing
18 Feb 2026

Browse the archive

Full archive